Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 01, 2018 Filed Feb 13, 2019 23:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 160 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-003861 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares held by Jean-Jacques Bienaime Family Trust

Disclosed balance after: 181,341

F1 · date: On May 1, 2018 the reporting person gifted 160 shares to an educational institution.

Read SEC document
April 30, 2018 Filed May 9, 2018 22:41 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 309 $68.78 $21,253.64
Disclosure

SEC source: 0001140361-18-022619 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,223

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2018 Filed May 15, 2018 01:28 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 309 $68.78 $21,253.64
Disclosure

SEC source: 0001140361-18-023474 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,600

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 312 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 52 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.

Read SEC document
April 30, 2018 Filed May 15, 2018 00:43 UTC
Mueller BrianSVP, Corporate Controller
GrantCommon Stock 287 $68.78 $19,740.43
Disclosure

SEC source: 0001140361-18-023458 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,846

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2018 Filed Jun 7, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 309 $68.78 $21,253.64
Disclosure

SEC source: 0001140361-18-027609 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,101

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 139 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 23 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.

Read SEC document
April 30, 2018 Filed Jun 7, 2018 00:21 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 309 $68.78 $21,253.64
Disclosure

SEC source: 0001140361-18-027607 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,364

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 79 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 13 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.

Read SEC document
April 30, 2018 Filed Jun 7, 2018 00:15 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 167 $68.78 $11,486.59
Disclosure

SEC source: 0001140361-18-027605 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,781

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 86 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 15 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.

Read SEC document
April 30, 2018 Filed Jun 7, 2018 00:01 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 309 $68.78 $21,253.64
Disclosure

SEC source: 0001140361-18-027599 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,838

F1 · date: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 84 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 14 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.

Read SEC document
April 24, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 24, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $82.29 $822,887.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,031

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $81.76 to $83.29. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 24, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
April 23, 2018 Filed Apr 26, 2018 00:37 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 11,059 $82.15 $908,496.85
Disclosure

SEC source: 0001140361-18-019613 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,543

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 11, 2017.

Read SEC document
April 23, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 23, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $82.58 $825,811.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,031

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $82.20 to $82.95. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 23, 2018 Filed Apr 26, 2018 00:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-019611 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-019440 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $83.65 $836,458.00
Disclosure

SEC source: 0001140361-18-019440 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,031

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $83.285 to $83.93. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-019440 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
April 17, 2018 Filed Apr 19, 2018 23:19 UTC Exercise / conversionStock Option (right to buy Common Stock) · Derivative 3,750 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-019095 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
April 17, 2018 Filed Apr 19, 2018 23:19 UTC SaleCommon Stock 3,750 $85.00 $318,750.00
Disclosure

SEC source: 0001140361-18-019095 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,860

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
April 17, 2018 Filed Apr 19, 2018 23:19 UTC Exercise / conversionCommon Stock 3,750 $38.59 $144,712.50
Disclosure

SEC source: 0001140361-18-019095 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
April 05, 2018 Filed Apr 9, 2018 19:51 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-017793 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 05, 2018 Filed Apr 9, 2018 19:51 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $14.39 $14,390.00
Disclosure

SEC source: 0001140361-18-017793 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 01:00 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 2,119 $80.12 $169,774.28
Disclosure

SEC source: 0001140361-18-016894 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,914

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:56 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-016888 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:56 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $14.39 $14,390.00
Disclosure

SEC source: 0001140361-18-016888 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,650 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · derivative · entry 6

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,681

Underlying: Common Stock · 6,650 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,350 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · derivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 3,350 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 6,650 $80.12 $532,798.00
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · nonDerivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,676

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 6,650 $37.46 $249,109.00
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 3,350 $80.12 $268,402.00
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,676

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 00:51 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 3,350 $26.49 $88,741.50
Disclosure

SEC source: 0001140361-18-016884 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
March 29, 2018 Filed Mar 31, 2018 00:03 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 1,537 $79.69 $122,483.53
Disclosure

SEC source: 0001140361-18-016271 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,033

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

Read SEC document
March 28, 2018 Filed Mar 30, 2018 23:58 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-016269 · doc1.xml · derivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 28, 2018 Filed Mar 30, 2018 23:58 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001140361-18-016269 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 1,000 shares

Expires 2018-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 28, 2018 Filed Mar 30, 2018 23:58 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $14.39 $14,390.00
Disclosure

SEC source: 0001140361-18-016269 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 28, 2018 Filed Mar 30, 2018 23:58 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $17.86 $17,860.00
Disclosure

SEC source: 0001140361-18-016269 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 22:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-015588 · doc1.xml · derivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 22:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $14.39 $14,390.00
Disclosure

SEC source: 0001140361-18-015588 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 26, 2018 Filed Mar 28, 2018 22:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-015588 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 26, 2018 Filed Mar 28, 2018 22:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $14.39 $14,390.00
Disclosure

SEC source: 0001140361-18-015588 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 23, 2018 Filed Mar 27, 2018 22:17 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 3,350 $81.35 $272,522.50
Disclosure

SEC source: 0001140361-18-015281 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,989

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

Read SEC document
March 22, 2018 Filed Mar 27, 2018 00:08 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Tax withholdingCommon Stock 3,583 $81.36 $291,512.88
Disclosure

SEC source: 0001140361-18-015081 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,602

Read SEC document
March 22, 2018 Filed Mar 27, 2018 00:02 UTC
Mueller BrianSVP, Corporate Controller
Tax withholdingCommon Stock 414 $81.36 $33,683.04
Disclosure

SEC source: 0001140361-18-015078 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,559

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:57 UTC
FUCHS HENRY JPresident, Worldwide R&D
Tax withholdingCommon Stock 5,812 $81.36 $472,864.32
Disclosure

SEC source: 0001140361-18-015075 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,676

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:50 UTC
Davis George EricEVP, General Counsel
Tax withholdingCommon Stock 3,295 $81.36 $268,081.20
Disclosure

SEC source: 0001140361-18-015071 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,339

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:45 UTC
BAFFI ROBERTEVP, Technical Operations
Tax withholdingCommon Stock 3,486 $81.36 $283,620.96
Disclosure

SEC source: 0001140361-18-015069 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,459

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:36 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 3,583 $81.36 $291,512.88
Disclosure

SEC source: 0001140361-18-015063 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,570

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-015059 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 1,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 22, 2018 Filed Mar 26, 2018 23:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Tax withholdingCommon Stock 13,075 $81.36 $1,063,782.00
Disclosure

SEC source: 0001140361-18-015059 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,031

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.